Mental Health Problems Experienced by Patients with Rheumatic Diseases During COVID-19 Pandemic
| Autor: | Khadija Berrada, Khawla Nadiri, Ilias Soussan, Siriman Coulibaly, Anass Adnine, Adil Najdi, Fatima Ezzahra Abourazzak |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
medicine.medical_specialty Generalized anxiety disorder 03 medical and health sciences 0302 clinical medicine Rheumatology Rating scale Rheumatic Diseases Internal medicine 0502 economics and business medicine Insomnia Humans Pandemics Socioeconomic status Depression (differential diagnoses) Aged 030203 arthritis & rheumatology business.industry Mental Disorders 05 social sciences COVID-19 Middle Aged medicine.disease Mental health Cross-Sectional Studies Mental Health Rheumatoid arthritis Anxiety Female Self Report medicine.symptom business 050203 business & management |
| Zdroj: | Current Rheumatology Reviews. 17:303-311 |
| ISSN: | 1573-3971 |
| DOI: | 10.2174/1573397117666210127124544 |
| Popis: | Background: Patients with rheumatic diseases are more likely to suffer from anxiety, depression and insomnia. Yet, little is known about mental health status during COVID-19 pandemic. Objective : This study aims to measure the prevalence of mental health disorders among patients with rheumatic diseases in the era of COVID-19 pandemic and to determine potential risk factors for major symptoms of depression, anxiety, and insomnia in participants. Methods: Participants with rheumatic diseases were asked to complete a questionnaire using a telephonic interview. Sociodemographic and rheumatic disease characteristics were recorded. Mental health status was assessed by the patient health questionnaire-9 (PHQ-9), generalized anxiety disorder (GAD)-7, and insomnia severity index (ISI) questionnaires to detect depression, anxiety and insomnia symptoms, respectively. Results : We included 307 patients in the survey. Rheumatoid arthritis was the most frequent diagnosis (55%). Of all participants, 7.5% had known depression and 5.5% known anxiety. Mental health disorders were insomnia (34.9%), anxiety (33.2%), and depression (24.4%). Major symptoms of insomnia, anxiety, and depression were noted in respectively, 19.9%, 12.4%, and 7.8% of participants. Risk factors for major insomnia were male gender (OR= 4.36, 95% CI 2.06 to 9.25; p Conclusions : A high frequency of undiagnosed depression, anxiety and insomnia symptoms was found in rheumatic patients. Rheumatologists should be aware of these comorbidities, especially in the era of COVID-19 pandemic. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|